Ken Margulies
Ken Margulies
#WordsMatter Continued: Moving Beyond "Stable" Toward Precision and Purpose [0.03%]
字字珠玑 II：追求精确与目标而非空谈稳定
Anuradha Lala,Robert J Mentz
Anuradha Lala
Corrigendum to "Individual Natriuretic and Diuretic Response in Acute Heart Failure: Insights from the PUSH-AHF Pharmacologic Substudy", Journal of Cardiac Failure volume 31 (2025) P1578-1581/ PMID: 40414278 [0.03%]
关于“急性心力衰竭中个体钠尿和利尿反应的见解：来自PUSH-AHF药理亚研究的结果”的勘误，发表于《心脏衰竭杂志》第31卷(P1578-1581/ PMID: 40414278)
Iris E Beldhuis,Jozine M Ter Maaten,Peter van der Meer et al.
Iris E Beldhuis et al.
The Canadian Heart Failure Society (CHFS) Workforce Committee Report 2024: Addressing the Challenges Facing the Heart Failure Physicians Workforce in Canada CHFS 2024 Heart Failure Workforce Report [0.03%]
加拿大心力衰竭协会(CHFS) 2024年劳动力委员会报告：解决加拿大心力衰竭医师劳动力面临的挑战 CHFS 2024 年心力衰竭劳动力报告
Aws Almufleh,Darshan H Brahmbhatt,Filio Billia et al.
Aws Almufleh et al.
Heart failure (HF) is a major contributor to morbidity, mortality, and healthcare resource utilization in Canada. Despite its growing burden, the HF physician workforce has not grown to meet this rising demand. Recognizing this critical gap...
Trends in Use and Early Outcomes of Ex Vivo Machine Perfusion in Heart Transplantation From Donation After Brain Death Donors [0.03%]
脑死亡供者心脏移植中体外机械灌注的应用趋势及近期结果分析
Shivank Madan,Lorenzo D&#x;Angelo,Jill Teitelbaum et al.
Shivank Madan et al.
Introduction: Hearts from donation after brain death (DBD) donors are increasingly older and transported over greater distances, prolonging ischemic times and increasing ischemic injury risks with conventional static cold...
Elena M Donald,Andrew J Sauer
Elena M Donald
Refining Atrial Shunt Therapy for HFpEF: Lessons from Pivotal Randomized Trials and Emerging Directions [0.03%]
HFpEF心房分流治疗的优化：关键随机试验的启示及未来方向
Dylan J Gyberg,Jan Komtebedde,Uma Mylavarapu et al.
Dylan J Gyberg et al.
Heart failure (HF) with preserved ejection fraction (HFpEF) is a challenging and heterogenous condition with limited effective treatments. Elevated left atrial pressure is a key driver of HF symptoms and complications, making it a compellin...
The Kazakhstan Model for Heart Failure Care: A Nationally Integrated Approach to Advanced Cardiac Therapy [0.03%]
哈萨克斯坦心力衰竭护理模式：先进心脏治疗的国家一体化方法
Makhabbat Bekbossynova,Saltanat Andossova,Saltanat Jetybayeva-Gerchek et al.
Makhabbat Bekbossynova et al.
Navigating Scarcity: How we enhanced HF service delivery in a resource constrained healthcare system [0.03%]
应对资源限制：改善医疗服务供给体系的方法
Nicola Melarkey,Edith Donnelly,P Campbell
Nicola Melarkey
Impact of Atrial Fibrillation, Diabetes Mellitus and Obesity on Outcomes with Aspirin Avoidance and Hemocompatibility with a Left Ventricular Assist Device: An analysis from the ARIES-HM3 Trial [0.03%]
房颤、糖尿病和肥胖对避免使用阿司匹林及心脏辅助装置血液相容性的影响——来至ARIES-HM3试验的事后分析
Nir Uriel,Ivan Netuka,Ulrich P Jorde et al.
Nir Uriel et al.
Background: The ARIES-HM3 trial demonstrated the safety and effectiveness of aspirin elimination from the antithrombotic regimen after HeartMate 3 (HM3) LVAD implantation. We explored the interaction of atrial fibrillatio...